We are thrilled to introduce our newest webinar in the "Genomics Unlocked" series: "SpaTial Enhanced REsolution Omics-sequencing New Frontiers of Spatial Multi-omics"
Explore MGI's latest achievement as its DNBSEQ-T20×2 gene sequencing platform wins the prestigious Globee® for Medical Equipment in the 15th Annual 2023 Golden Bridge Business and Innovation Awards®. This post highlights MGI's commitment to innovation in the life science industry, their groundbreaking T20 gene sequencer, and how their technology is reshaping healthcare outcomes and the genetic industry.
Discover the groundbreaking partnerships and innovations unveiled by MGI Tech Co., Ltd. at the ESHG Conference in Glasgow. Learn about MGI's strategic collaborations in the European life sciences market, their advancements in sequencing and automation technologies, and their commitment to revolutionizing genomics research. This post also highlights MGI's strategic partnership with Alithea Genomics, aiming to innovate in RNA sequencing.
Discover the strategic collaboration between MGI Tech Co. Ltd., a global leader in life science technology, and AddLife AB, a major European distributor of clinical testing and laboratory equipment. Learn how this partnership aims to revolutionize life science in the Nordic region through the distribution of MGI's innovative products and expansion into fields like point-of-care testing and remote ultrasound.
MGI's award-winning DNBSEQ-T20×2* gene sequencing platform revolutionizes DNA sequencing in healthcare, offering unparalleled throughput and cost-efficiency for researchers and clinicians.
Explore MGI Tech Co. Ltd.'s significant contributions to the Million Microbiome of Humans Project (MMHP), a collaborative effort aiming to construct a comprehensive microbiome map of the human body. This post highlights MGI's innovative sequencing technology, the importance of microbiome in human health, and the future of microbiomics in precision medicine. Discover how MGI is reshaping the future of microbiome research and healthcare.
MGI Tech Co., Ltd. launches an overseas production line in Latvia to assemble the advanced DNBSEQ-G400* gene sequencing instruments and HotMPS** reagents, marking a significant milestone in MGI's expansion into the European market.
GNOMIX, a global genetics lab renowned for its diverse services, embraces MGI's role in stimulating market competition and shaping the genomics sector.
Celebrating the MGISP-Smart 8's European launch and our Empowerment Program at MEDICA, MGI continues to pioneer genomics research through steadfast innovation.
"We are delighted to be bringing our proven DNBSEQ™ technology to customers and partners in Germany once again," said Dr. Yong Hou.
Latvian Biomedical Research Center Uses MGI's Sequencing Platform for Faster and More Efficient Virus Sequencing in the Fight against the Global Pandemic.
Unveiling MGI's Customer Experience Center in Berlin: Empowering Precision Medicine. Explore MGI's new Customer Experience Center in Berlin, Germany, fostering precision medicine through innovative automation and sequencing. Revolutionize cancer diagnostics, personalized oncology services, and cutting-edge technologies.
NGC, a top genetic disease diagnosis center in Turkey, utilizes MGI's sequencing technology and platform for stable and accurate data results in their high-quality genetic testing services.
MGI Revolutionizes Agrigenomics Research and Molecular Breeding with Advanced Sequencing Technology and Platforms. Discover the Future of Agriculture with MGI's Innovations.
07.09 - 09.09.2022
The 17th Annual Meeting of the International Conference on Genomics (ICG-17) was held on-site and online in Riga, Latvia (OMICS Advances in Africa and Europe, September 7-9).
Pig Breeding Revolution: Prof. Zhao Shuhong and team at Huazhong Agricultural University are reshaping China's industry with groundbreaking genomics research. Explore the future of pig breeding.